On 6 May 2025, the Beneluxa Initiative organised a meeting that brought together representatives from the Belgian and Dutch advisory bodies on medicines reimbursement: the CRM (Commission for the Reimbursement of Medicines, Belgium), WAR (Scientific Advisory Board, Netherlands), and ACP (Advisory Committee on the Basic Health Insurance Package, Netherlands). Subject of the meeting: from assessment to appraisal. The Beneluxa Initiative successfully completed multiple joint Health Technology Assessments. This session provided a valuable opportunity for participants to gain deeper insight into each other’s procedures and to discuss avenues for enhanced collaboration during the pre-appraisal phase of a joint Beneluxa process.
Last update: 23 June 2025